Denali Therapeutics Inc. (DNLI)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
54.30+0.33 (+0.61%)
At close: 4:00PM EDT
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 53.97 |
| Open | 54.34 |
| Bid | 51.52 x 1400 |
| Ask | 55.95 x 800 |
| Day's Range | 53.49 - 55.69 |
| 52 Week Range | 17.51 - 93.94 |
| Volume | 310,208 |
| Avg. Volume | 592,948 |
| Market Cap | 6.58B |
| Beta (5Y Monthly) | 1.93 |
| PE Ratio (TTM) | 110.37 |
| EPS (TTM) | 0.49 |
| Earnings Date | Aug 05, 2021 - Aug 09, 2021 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 79.11 |
- Simply Wall St.
Bearish: Analysts Just Cut Their Denali Therapeutics Inc. (NASDAQ:DNLI) Revenue and EPS estimates
The latest analyst coverage could presage a bad day for Denali Therapeutics Inc. ( NASDAQ:DNLI ), with the analysts...
- Zacks
Denali's (DNLI) Q1 Earnings Miss Estimates, Revenues Up Y/Y
Denali (DNLI) posts a wider-than-expected loss in the first quarter of 2021 due to higher R&D costs.
- Zacks
Denali Therapeutics Inc. (DNLI) Reports Q1 Loss, Misses Revenue Estimates
Denali Therapeutics Inc. (DNLI) delivered earnings and revenue surprises of -56.76% and -72.76%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
© 2021 Verizon Media. All rights reserved.
